A $3 Million Gene-Therapy Maker at a Bargain Price

Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.

  School   Aug 20, 2024   0   37  Add to Reading List
Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.
Read More